Certified by Founder Lodge
CardioMech AS
Norway - Trondheim
START UP
1 Disclosed Funding Rounds $13,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mitral Regurgitation is the third most common cardiovascular disease that occurs when there is backward flow of blood across the mitral valve. It is highly prevalent, debilitating for patient
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 03 ,2024 | Unknown | $13,000,000 |
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
